Literature DB >> 16490473

Hereditary angioedema: new findings concerning symptoms, affected organs, and course.

Konrad Bork1, Gabriele Meng, Petra Staubach, Jochen Hardt.   

Abstract

PURPOSE: Hereditary angioedema (HAE) due to C1 inhibitor deficiency is clinically characterized by relapsing skin swellings, abdominal pain attacks, and life-threatening upper airway obstruction. Our aim was to examine a temporal and spatial pattern of the edema episodes by evaluating the long-term course of hereditary angioedema in order to establish a specific swelling pattern. SUBJECTS AND METHODS: Data were generated from 221 patients with C1 inhibitor deficiency by asking them about symptoms they experienced during their edema episodes. Documentation was accomplished through the use of standardized questionnaires.
RESULTS: A total of 131110 edema episodes were observed. Clinical symptoms started at a mean age of 11.2 (SD 7.7) years. During the following cumulative 5736 years, only 370 (6.5%) symptom-free years occurred. Skin swellings, including extremity, facial, genital, and trunk swellings, and abdominal attacks occurred in 97.4% of all edema episodes of the disease. The other episodes were laryngeal edema (0.9%); edema of the soft palate (0.6%); tongue swellings (0.3%); headache episodes (0.7%); episodes affecting urinary bladder (0.3%), chest (0.2%), muscles (0.4%), joints (0.1%), kidneys (0.1%), and esophagus (0.05%), and were partly combined with other edema episodes. The per-patient analysis and the per-episode analysis revealed markedly discrepant results. On average, women had a more severe course of the disease than men. Patients with early onset of clinical symptoms were affected more severely than those with late onset.
CONCLUSION: The described swelling pattern is specific for HAE and allows a tentative diagnosis based on clinical symptoms and the course of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490473     DOI: 10.1016/j.amjmed.2005.09.064

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  135 in total

1.  Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods.

Authors:  Judit Czúcz; Gyula Schaffer; Dorottya Csuka; Szilvia Walentin; Jan Kunde; Zoltán Prohászka; Henriette Farkas; László Cervenak
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

2.  C1 esterase inhibitor (human).

Authors: 
Journal:  P T       Date:  2010-07

Review 3.  The new era of C1-esterase inhibitor deficiency therapy.

Authors:  Louanne Marie Tourangeau; Bruce L Zuraw
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

4.  Improving patient outcomes in hereditary angioedema: reducing attack frequency using routine prevention with C1 inhibitor concentrate.

Authors:  Nina Dominas; Thomas K Hoffmann; Murat Bas; Jens Greve
Journal:  BMJ Case Rep       Date:  2014-05-21

5.  [Hereditary metabolic diseases with cutaneous manifestations : An update].

Authors:  J Frank; P Poblete-Gutiérrez
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 6.  New therapeutics in C1INH deficiency: a review of recent studies and advances.

Authors:  Neil Parikh; Marc A Riedl
Journal:  Curr Allergy Asthma Rep       Date:  2011-08       Impact factor: 4.806

Review 7.  Pharmacological Management of Hereditary Angioedema with C1-Inhibitor Deficiency in Pediatric Patients.

Authors:  Henriette Farkas
Journal:  Paediatr Drugs       Date:  2018-04       Impact factor: 3.022

8.  Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy.

Authors:  Roman Hakl; Pavel Kuklínek; Irena Krčmová; Pavlína Králíčková; Tomáš Freiberger; Petr Janků; Marcela Vlková; Jiří Litzman
Journal:  J Clin Immunol       Date:  2018-10-02       Impact factor: 8.317

9.  Anesthesia management for emergency laparotomy in a pediatric patient with suspected hereditary angioedema.

Authors:  Tomoko Yazawa; Toyohiko O'higashi; Hiroki Daijo; Tetsutaro Shinomura
Journal:  J Anesth       Date:  2010-01-06       Impact factor: 2.078

10.  Hereditary angioedema: New therapeutic options for a potentially deadly disorder.

Authors:  Frank J Eidelman
Journal:  BMC Blood Disord       Date:  2010-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.